NCT07679984

Brief Summary

The purpose of this study is to evaluate the effectiveness of adding the Mindfulness in Motion (MIM) program to usual primary care for people with high blood pressure. MIM is a facilitated, 8-week online program that teaches simple ways to manage stress using mindfulness practices. The program also includes the use of a companion smartphone app throughout the 12-month study period. In this study, investigators will compare people who receive their usual care and take part in the MIM program with those who receive usual care alone to see if it helps improve blood pressure, weight, stress, sleep, and overall well-being. Over 12 months, participants will be asked to complete short questionnaires about stress, sleep, and resilience four times via a smartphone, tablet, or computer.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
19mo left

Started Oct 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 1, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2027

7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

July 6, 2026

Status Verified

June 1, 2026

Enrollment Period

1 year

First QC Date

June 22, 2026

Last Update Submit

July 1, 2026

Conditions

Keywords

hypertensionprimary caremindfulnessstressresiliencesleepblood pressure

Outcome Measures

Primary Outcomes (2)

  • Systolic and Diastolic Blood Pressure

    Blood pressure, obtained at each Family Medicine ambulatory appointment, is the force exerted by circulating blood against the walls of blood vessels due to heart's pumping action. It is measured in mmHg. The upper number is the measurement during the heartbeat (systolic) and the lower number is while the heart is at rest (diastolic). In the office, this measurement will be taken manually by trained medical assistants using GE Healthcare CRITIKON DURA-CUF reusable cuff and 767-Series wall/mobile sphygmomanometer in clinic and recorded in the patient's electronic medical record.

    At baseline and at the end of the 12-month study

  • Height/Weight_BMI

    Body Mass Index (BMI) is an auto calculation in the electronic medical record reflecting the indirect measure of body fat derived by dividing weight in kilograms by height in meters, squared. For adults 20 years of age and older, a BMI below 18.5 is considered underweight, a BMI between 18.5 and 24.9 is considered a healthy weight, a BMI of 25.0 to 29.9 is defined as overweight, and a BMI greater than 30.0 is defined as obesity.

    At baseline and at the end of the 12-month study period

Secondary Outcomes (3)

  • Perceived Stress Scale-10

    At baseline, at 2-months, 6-months, and at the end of the 12-month study period.

  • Connor-Davidson Resilience Scale-10

    At baseline, 2-month assessment, 6-month assessment, and at end of the 12-month study period.

  • PROMIS Sleep Disturbance Scale

    At baseline, 2-month assessment, 6-month assessment, and at the end of the 12-month study period.

Other Outcomes (3)

  • Mindfulness in Motion Attendance

    At the end of the 12-month study period

  • Mindfulness in Motion App Usage total time per 12-month study period

    At the end of the 12-month study period.

  • Mindfulness in Motion mean app usage per day

    At the end of the 12-month study period.

Study Arms (2)

Mindfulness in Motion plus Usual Care (Intervention Group)

EXPERIMENTAL
Behavioral: Mindfulness in Motion

Usual Care (Control Group)

NO INTERVENTION

Interventions

Mindfulness in Motion (MIM) is an 8-week evidence-based program designed as an intervention to help participants learn practical burnout/stress reduction and resiliency building techniques. Delivered in a virtual, synchronous group format one hour per week, MIM includes didactic instruction, community-building group discussion, mindfulness, and gentle yoga. Each session focuses on a specific theme with topics that include Willingness to Daily Practice, Cultivating Mindful Sleep, Vision of Self, Supported by the Breath, Mindful Eating and Yoga, Movement Through Balance, Awareness of Sensation, Clarity and Release, and Staying Grounded \& Moving Forward. Participants are highly encouraged to engage in 10-20 minutes of individual self-practice at least five times per week. A companion MIM smartphone app offers daily mindfulness, movement, and reflective practices.

Mindfulness in Motion plus Usual Care (Intervention Group)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years old.
  • Established patient at OSU Family Medicine
  • Diagnosis of primary essential hypertension
  • Ability and willingness to participate in all Mindfulness in Motion (MIM) study activities.
  • Ability and willingness to download MyCap, the smartphone app that securely links participant study responses to the REDCap study project.
  • WiFi connectivity or LTE to allow use of MIM smartphone app and MyCap when not at OSU clinical site.

You may not qualify if:

  • Inability to read and/or understand English (MIM intervention, study consent and questionnaires in English).
  • Established mindfulness practice.
  • Diagnosis of secondary hypertension with identifiable underlying causes including:
  • Chronic kidney disease
  • Renal artery stenosis
  • Primary aldosteronism
  • Cushing's syndrome
  • Pheochromocytoma
  • Obstructive sleep apnea
  • Medication induced hypertension (e.g., steroids, NSAIDs)
  • Pregnancy related hypertension
  • Current severe alcohol or substance abuse disorder.
  • Participants with documented cognitive disorder that limits the ability to independently participate in MIM program, read, understand, and/or complete the surveys; i.e. dementia, Alzheimer's or biological tests.
  • Participants with major psychiatric disorders not controlled by medication or other psychiatric treatments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

HypertensionEssential Hypertension

Interventions

MindfulnessMotion

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesPhysical Phenomena

Central Study Contacts

Beth Steinberg, PhD, RN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Director of Research

Study Record Dates

First Submitted

June 22, 2026

First Posted

July 1, 2026

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

October 1, 2027

Study Completion (Estimated)

May 1, 2028

Last Updated

July 6, 2026

Record last verified: 2026-06

Locations